kedarmal shankarlal bankda's most recent trade in Syncom Formulation (India) Ltd. was a Acquisition of 2,731,470 Equity Shares done . Disclosure was reported to the exchange on June 16, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for kedarmal shankarlal bankda in the Trendlyne database.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Syncom Formulation | Kedarmal Shankarlal Bankda | Promoter & Director | Acquisition | 16 Jun 2023 | 2,731,470 | 116,926,120 (12.44%) | 0.29% | 0 | 0 | 15 Jun 2023 15 Jun 2023 |
Insider Trading | Equity Shares | Off Market |
Syncom Formulation | Kedarmal Shankarlal Bankda | Promoter | Acquisition | 09 Jun 2022 | 24,000,000 | 114,194,650 (12.15%) | 2.78% | 2.5 | 60,720,000 | 28 May 2022 28 May 2022 |
Insider Trading | Equity Shares | Conversion of security |